Table 2.
Distribution of WiDr Cell Cycle after Treatment with PNF
| Treatment | Concentration μg/mL | % Cell phase | ||
|---|---|---|---|---|
| G0-G1 | S | G2-M | ||
| Cell control | 0 | 46.18 ± 0.35 | 27.84 ± 0.27 | 26.96 ± 0.26 |
| Polyisoprenoids from N. fruticans | 18 (1/10 IC50) | 61.91 ± 0.18 | 21.66 ± 0.33 | 16.34 ± 0.29 |
| 36 (1/5 IC50) | 62.87 ± 0.23 | 18.57 ± 0.22 | 17.42 ± 0.24 | |
| 90 (1/2 IC50) | 69.82 ± 0.16 | 15.57 ± 0,31 | 14.31 ± 0,12 | |
| 180 (1 IC50) | 70.36 ± 0.12 | 14.64 ± 0.28 | 14.61 ± 0.14 | |
Data were expressed as mean ± SD (n=3)